MRC1 and neoplasm: This trivalent system preferably enables the dual-targeting to cancer-associated fibroblast and tumor-associated macrophage-specific MRs (CD206 and CD280), which resulted in a seven times stronger suppression of melanoma growth in B16F10 tumor-bearing mice, when the effect is compared to PEGylated albumin [95].